We are live on ! Find out more
William Blair & Company

William Blair & Company Portfolio holdings

AUM $38.4B
1-Year Est. Return 25.71%
This Fund
S&P 500
This Quarter Est. Return
+9.7%
1 Year Est. Return
+25.71%
3 Year Est. Return
+88.7%
5 Year Est. Return
+104.53%
10 Year Est. Return
+665.86%
AUM
$27.3B
AUM Growth
+$2.26B
Cap. Flow
+$202M
Cap. Flow %
0.74%
Top 10 Hldgs %
24.36%
Holding
1,897
New
97
Increased
682
Reduced
737
Closed
88

Top Buys

Rank Stock Value
1
COST icon
Costco
COST
+$28.3M
2
ALL icon
Allstate
ALL
+$25.8M
3
ISRG icon
Intuitive Surgical
ISRG
+$19.6M
4
NEOG icon
Neogen
NEOG
+$17.4M
5
DV icon
DoubleVerify
DV
+$17.3M

Top Sells

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$29.1M
2
PLNT icon
Planet Fitness
PLNT
+$20.4M
3
ABNB icon
Airbnb
ABNB
+$17.1M
4
IBM icon
IBM
IBM
+$14.8M
5
XMTR icon
Xometry
XMTR
+$10.8M

Sector Composition

Rank Sector Weight
1 Technology 25.59%
2 Healthcare 18.44%
3 Industrials 11.64%
4 Financials 11.51%
5 Consumer Discretionary 8.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCHV
1001
Schwab US Large-Cap Value ETF
SCHV
$16.3B
$580K ﹤0.01%
25,926
+135
+0.5% +$2.95K
TDOC icon
1002
Teladoc Health
TDOC
$1.26B
$577K ﹤0.01%
22,806
+2,087
+10% +$52.5K
ONB icon
1003
Old National Bancorp
ONB
$10.4B
$572K ﹤0.01%
41,055
-2,844
-6% -$37.8K
JHMM icon
1004
John Hancock Multifactor Mid Cap ETF
JHMM
$6.18B
$571K ﹤0.01%
11,487
-1,508
-12% -$71.6K
LW icon
1005
Lamb Weston
LW
$7.39B
$570K ﹤0.01%
4,956
-153
-3% -$17.1K
RILY icon
1006
BRC Group Holdings
RILY
$303M
$567K ﹤0.01%
12,329
-4,415
-26% -$155K
KSS icon
1007
Kohl's
KSS
$2.22B
$566K ﹤0.01%
24,563
+1,026
+4% +$22.2K
WAL icon
1008
Western Alliance Bancorporation
WAL
$8.92B
$564K ﹤0.01%
15,473
+8,077
+109% +$280K
EUSA icon
1009
iShares MSCI USA Equal Weighted ETF
EUSA
$1.96B
$564K ﹤0.01%
7,159
PEG icon
1010
Public Service Enterprise Group
PEG
$37.8B
$564K ﹤0.01%
9,010
-2,272
-20% -$142K
DCI icon
1011
Donaldson
DCI
$11.1B
$562K ﹤0.01%
8,996
-951
-10% -$59.5K
JEF icon
1012
Jefferies Financial Group
JEF
$12.9B
$558K ﹤0.01%
+16,837
New +$525K
TWST icon
1013
Twist Bioscience
TWST
$7.86B
$555K ﹤0.01%
27,108
-17,796
-40% -$267K
IGV icon
1014
iShares Expanded Tech-Software Sector ETF
IGV
$15.2B
$551K ﹤0.01%
7,970
+830
+12% +$52.1K
SPYV icon
1015
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.8B
$549K ﹤0.01%
12,702
+1,146
+10% +$47.3K
OXY icon
1016
Occidental Petroleum
OXY
$57.7B
$548K ﹤0.01%
9,328
-2,077
-18% -$125K
UUP icon
1017
Invesco DB US Dollar Index Bullish Fund
UUP
$414M
$547K ﹤0.01%
19,276
+2,500
+15% +$70.2K
GTIP icon
1018
Goldman Sachs Access Inflation Protected USD Bond ETF
GTIP
$296M
$547K ﹤0.01%
11,135
+96
+0.9% +$4.76K
UEC icon
1019
Uranium Energy
UEC
$5.54B
$546K ﹤0.01%
160,500
MGPI icon
1020
MGP Ingredients
MGPI
$389M
$545K ﹤0.01%
5,130
+1,475
+40% +$147K
EPP icon
1021
iShares MSCI Pacific ex Japan ETF
EPP
$2.24B
$545K ﹤0.01%
12,898
-2,836
-18% -$123K
DLTH icon
1022
Duluth Holdings
DLTH
$151M
$543K ﹤0.01%
86,529
THW
1023
abrdn World Healthcare Fund
THW
$560M
$543K ﹤0.01%
38,706
+25
+0.1% +$354
BURL icon
1024
Burlington
BURL
$22.4B
$542K ﹤0.01%
3,443
+541
+19% +$92.8K
MKTX icon
1025
MarketAxess Holdings
MKTX
$5.72B
$539K ﹤0.01%
2,062
-689
-25% -$206K

Similar funds

William Blair & Company's Q2 2023 Portfolio in Review

As of Q2 2023, William Blair & Company held 1,897 positions worth $27.3B, up 9% from $25B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

William Blair & Company's Q2 2023 filing shows 97 new, 682 increased, 737 reduced and 88 closed positions. Its largest new stake was Innovator US Equity Power Buffer ETF April: 112,249 shares worth $3.47M. The largest sale was Neurocrine Biosciences, an estimated $29.1M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.

  • William Blair & Company's largest Q2 2023 buy was Innovator US Equity Power Buffer ETF April: 112,249 shares worth $3.47M.
  • William Blair & Company added most to Costco in Q2 2023, an estimated $28.3M increase.
  • William Blair & Company's biggest Q2 2023 reduction was Neurocrine Biosciences, cutting an estimated $29.1M.
  • William Blair & Company fully exited ABB Ltd in Q2 2023, selling an estimated $7.21M.
  • William Blair & Company's ten largest holdings make up 24% of its $27.3B portfolio in Q2 2023.
  • William Blair & Company opened 97 new positions and closed 88 in Q2 2023.
  • William Blair & Company's portfolio value rose 9% quarter-over-quarter to $27.3B.

Based on William Blair & Company's 13F filing for Q2 2023, filed 11 Aug 2023.